Legal status by country
Is ANP legal?
Written by Aaron CuhaReviewed Sep 2026
How ANP is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Not approved | Not approved | Not approved | Not approved |
| Classification | Not approved | Not licensed | Not registered | Not approved |
| Note | No ANP or carperitide product was found in Drugs@FDA on 11 September 2026. The natriuretic peptide the FDA did approve is nesiritide, a recombinant B-type natriuretic peptide, and that product is now discontinued. | None recorded | None recorded | None recorded |
US FDA status: Not FDA approved. No ANP or carperitide product was returned by the Drugs@FDA query on 11 September 2026. Carperitide is described in the clinical literature as in use for acute heart failure in Japan; this site did not verify that approval with the Japanese regulator and does not state its date or terms.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.